Literature DB >> 9035302

Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case.

H Onodera1, R Nishitai, K Shimizu, S Maetani, M Imamura.   

Abstract

A case of poorly differentiated adenocarcinoma of the small bowel with extensive lymph node metastases is herein presented, which responded to methotrexate/5-fluorouracil (MTX/5-FU) sequential therapy. The lymph node metastases disappeared completely after 10 months of treatment. After recurrence, combination therapy with radiation, hyperthermia, and cisplatinum were also effective in reducing the degree of nodal swelling while still allowing the patient to maintain her accustomed lifestyle for a prolonged period of time. Further multi-institutional studies are still needed, however, to fully assess this new therapeutic regimen for small bowel cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9035302     DOI: 10.1007/bf01366941

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Primary neoplasms of the small intestine.

Authors:  R M Zollinger
Journal:  Am J Surg       Date:  1986-06       Impact factor: 2.565

2.  Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.

Authors:  P Preusser; H Wilke; W Achterrath; U Fink; P Neuhaus; J Meyer; H J Meyer; J van de Loo
Journal:  Recent Results Cancer Res       Date:  1988

3.  Why are small-bowel tumours so rare?

Authors:  A B Lowenfels
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

4.  Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.

Authors:  J R Bertino; W L Sawicki; C A Lindquist; V S Gupta
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

Review 5.  How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

Authors:  M M Gottesman
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

6.  The effect of methotrexate pretreatment on 5-fluorouracil kinetics in sarcoma 180 in vivo.

Authors:  R Herrmann; W Kunz; H Osswald; M Ritter; R Port
Journal:  Eur J Cancer Clin Oncol       Date:  1985-06

7.  Adenocarcinoma of the small intestine.

Authors:  K Ouriel; J T Adams
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

8.  Primary malignancies of the small bowel: a report of 96 cases and review of the literature.

Authors:  J M Wilson; D B Melvin; G F Gray; B Thorbjarnarson
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

9.  Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.

Authors:  E Cadman; R Heimer; L Davis
Journal:  Science       Date:  1979-09-14       Impact factor: 47.728

Review 10.  Malignant tumours of the small bowel.

Authors:  J H Donohue
Journal:  Surg Oncol       Date:  1994-04       Impact factor: 3.279

View more
  3 in total

1.  Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.

Authors:  Tatjana Eigenbrod; Frank Kullmann; Frank Klebl
Journal:  Int J Gastrointest Cancer       Date:  2006

2.  Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinoma.

Authors:  Yoshihiro Shibata; Eishi Baba; Hiroshi Ariyama; Shuji Arita; Taichi Isobe; Hitoshi Kusaba; Kenji Mitsugi; Shuji Nakano; Koichi Akashi
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

3.  Chemotherapy for small-bowel Adenocarcinoma at a single institution.

Authors:  Mitsukuni Suenaga; Nobuyuki Mizunuma; Keisho Chin; Satoshi Matsusaka; Eiji Shinozaki; Masatoshi Oya; Masashi Ueno; Toshiharu Yamaguchi; Tetsuichiro Muto; Fumio Konishi; Kiyohiko Hatake
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.